NASDAQ:VRCA | Profit Breakdown | Verrica Pharmaceuticals Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$5.86M-$13.1M-$13.15M
2026-03-31$5.02M-$9.72M-$9.68M
2025-12-31$5.09M-$7.19M-$8.07M
2025-09-30$14.34M$1.63M-$274,000.00
2025-06-30$12.7M$1.51M$204,000.00
2025-03-31$3.44M-$8.13M-$9.74M
2024-12-31$344,000.00-$11.41M-$16.2M
2024-09-30-$1.78M-$20.7M-$22.86M
2024-06-30$5.18M-$15.21M-$17.19M
2024-03-31$3.83M-$18.6M-$20.33M
2023-12-31$1.99M-$23.14M-$24.61M
2023-09-30$2.92M-$23.92M-$24.8M
2023-06-30$182,000.00-$11.62M-$10.99M
2023-03-31$37,000.00-$7.09M-$6.59M
2022-12-31$68,000.00-$6.21M-$5.93M
2022-09-30$8.32M$1.45M$83,000.00
2022-06-30$214,000.00-$9.12M-$10.17M
2022-03-31$431,000.00-$7.41M-$8.47M
2021-12-31$0.00-$8.47M-$9.54M
2021-09-30$0.00-$11.77M-$12.83M
2021-06-30$0.00-$10.73M-$11.78M
2021-03-31$12M$60,000.00-$936,000.00
2020-12-31-$12.03M-$12.98M
2020-09-30-$9.64M-$10.49M
2020-06-30-$8.63M-$9.41M
2020-03-31-$9.88M-$9.82M
2019-12-31-$7.99M-$7.64M
2019-09-30-$6.54M-$6.09M
2019-06-30-$7.52M-$7M
2019-03-31-$8.03M-$7.48M
2018-12-31-$8.19M-$7.58M
2018-09-30-$6.33M-$5.91M
2018-06-30-$5.47M-$5.32M
2018-03-31-$1.89M-$1.85M
2017-12-31-$1.43M-$1.44M
2017-09-30-$1.36M-$1.36M
2017-06-30-$1.1M-$1.1M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$35.58M-$12.19M-$17.89M
2024-12-31$7.57M-$65.92M-$76.58M
2023-12-31$5.12M-$65.76M-$67M
2022-12-31$9.03M-$21.3M-$24.49M
2021-12-31$12M-$30.91M-$35.08M
2020-12-31-$40.18M-$42.69M
2019-12-31-$30.08M-$28.21M
2018-12-31-$21.88M-$20.65M
2017-12-31-$4.46M-$4.46M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.